DK1054664T3 - Fremgangsmåde til modulering af makrofagaktivering - Google Patents

Fremgangsmåde til modulering af makrofagaktivering

Info

Publication number
DK1054664T3
DK1054664T3 DK99903869.8T DK99903869T DK1054664T3 DK 1054664 T3 DK1054664 T3 DK 1054664T3 DK 99903869 T DK99903869 T DK 99903869T DK 1054664 T3 DK1054664 T3 DK 1054664T3
Authority
DK
Denmark
Prior art keywords
macrophage activation
modulating macrophage
modulating
activation
macrophage
Prior art date
Application number
DK99903869.8T
Other languages
English (en)
Inventor
Celine Morissette
Francine Gervais
Original Assignee
Bhi Ltd Partnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bhi Ltd Partnership filed Critical Bhi Ltd Partnership
Application granted granted Critical
Publication of DK1054664T3 publication Critical patent/DK1054664T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK99903869.8T 1998-02-11 1999-02-11 Fremgangsmåde til modulering af makrofagaktivering DK1054664T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7429598P 1998-02-11 1998-02-11
US24839699A 1999-02-10 1999-02-10
PCT/IB1999/000354 WO1999040909A1 (en) 1998-02-11 1999-02-11 Method for modulating macrophage activation

Publications (1)

Publication Number Publication Date
DK1054664T3 true DK1054664T3 (da) 2012-11-05

Family

ID=26755484

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99903869.8T DK1054664T3 (da) 1998-02-11 1999-02-11 Fremgangsmåde til modulering af makrofagaktivering

Country Status (13)

Country Link
EP (1) EP1054664B1 (da)
JP (1) JP4574845B2 (da)
AU (1) AU2437899A (da)
CA (2) CA2632106A1 (da)
CY (1) CY1113205T1 (da)
DK (1) DK1054664T3 (da)
ES (1) ES2392391T3 (da)
HK (1) HK1032915A1 (da)
IL (1) IL137751A0 (da)
MX (2) MX2008014823A (da)
NZ (2) NZ568553A (da)
PT (1) PT1054664E (da)
WO (1) WO1999040909A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
MXPA00011213A (es) * 1998-05-15 2003-04-22 Neurochem Inc Uso de inhibidores de amiloides para la modulacion de la muerte de las celulas neuronales.
US6310073B1 (en) 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
ATE441421T1 (de) * 1999-04-28 2009-09-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
EP1237547A2 (en) * 1999-07-09 2002-09-11 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
EP1251837A2 (en) 1999-12-23 2002-10-30 Neurochem, Inc. Compounds and methods for modulating cerebral amyloid angiopathy
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
EA012325B1 (ru) * 2002-12-24 2009-08-28 Беллус Хелс (Интернэшнл) Лимитед Терапевтические составы для лечения болезней, связанных с наличием бета-амилоида
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
JP2007516940A (ja) * 2003-06-23 2007-06-28 ニューロケム （インターナショナル） リミテッド 改善された薬剤候補およびその調製法
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US7253306B2 (en) 2003-06-23 2007-08-07 Neurochem (International) Limited Pharmaceutical drug candidates and methods for preparation thereof
JP5145537B2 (ja) 2004-12-22 2013-02-20 ビーエイチアイ リミテッド パートナーシップ アミロイド関連疾患を治療するための方法および組成物
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
RU2432362C2 (ru) 2005-11-30 2011-10-27 Эбботт Лэборетриз Моноклональные антитела и их применения
ATE481094T1 (de) 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
PL3851447T3 (pl) 2006-10-12 2024-03-04 Bellus Health Inc. Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
SI2238166T1 (sl) 2007-10-05 2014-03-31 Genentech, Inc. Uporaba protitelesa proti amiloidu beta pri očesnih bolezni
WO2010094734A2 (en) * 2009-02-19 2010-08-26 Biofocus Dpi B.V. Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
AU2010295445B2 (en) * 2009-09-17 2014-09-25 Bespoke Bioscience, Llc Role of N-2 hydroxy-ethyl-piperazine-N'-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
CN103179981B (zh) 2010-07-30 2017-02-08 Ac免疫有限公司 安全和功能性的人源化抗β‑淀粉样蛋白抗体
WO2012024187A1 (en) 2010-08-14 2012-02-23 Abbott Laboratories Amyloid-beta binding proteins
WO2016163886A2 (en) * 2015-04-10 2016-10-13 Clues2Cure International B.V. Administration of taurine or an analog thereof for the treatment of nerve cell damage
CN109381452A (zh) * 2017-08-11 2019-02-26 江西青峰药业有限公司 乙基硫酸类化合物的应用及其制备方法
CN109381453A (zh) * 2017-08-14 2019-02-26 江西青峰药业有限公司 乙基硫酸钾在制备用于预防或治疗炎症性疾病药物中的应用
CN109394746A (zh) * 2017-08-15 2019-03-01 江西青峰药业有限公司 乙基硫酸铵在制备用于预防或治疗炎症性疾病药物中的应用
WO2023212289A1 (en) 2022-04-28 2023-11-02 Alzheon, Inc. Tramiprosate for treating apoe4-related diseases
WO2024119183A1 (en) 2022-12-02 2024-06-06 Alzheon, Inc. Methods for treating neurodegenerative disorders with tramiprosate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144937A (en) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections
US5087618A (en) * 1982-05-18 1992-02-11 University Of Florida Redox carriers for brain-specific drug delivery
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5276059A (en) * 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
DK1060750T3 (da) * 1993-03-29 2006-01-09 Univ Kingston Propan-1,3-disulfonsyre og dens farmaceutisk acceptable salte til behandling af amyloidose
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
IL134619A0 (en) * 1997-08-18 2001-04-30 Univ Kingston Phosphono-carboxylate compounds for treating amyloidosis

Also Published As

Publication number Publication date
MX2008014823A (es) 2009-03-06
ES2392391T3 (es) 2012-12-10
NZ550199A (en) 2008-07-31
HK1032915A1 (en) 2001-08-10
EP1054664B1 (en) 2012-08-08
WO1999040909A1 (en) 1999-08-19
NZ568553A (en) 2010-02-26
AU2437899A (en) 1999-08-30
JP4574845B2 (ja) 2010-11-04
EP1054664A1 (en) 2000-11-29
CA2320224A1 (en) 1999-08-19
CY1113205T1 (el) 2016-04-13
PT1054664E (pt) 2012-11-02
MXPA00007815A (es) 2002-04-24
JP2002502871A (ja) 2002-01-29
CA2320224C (en) 2008-08-12
IL137751A0 (en) 2001-10-31
CA2632106A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
DK1054664T3 (da) Fremgangsmåde til modulering af makrofagaktivering
DK1011309T3 (da) Fremgangsmåde til tilvejebringelse af forøget fotosyntese
DE69925400D1 (de) Lasersystem-Steuerung
DE69819044D1 (de) Vervielfacher für laserwiederholfrequenz
DE69719886D1 (de) Orthogonales Modulationsverfahren
DK0885968T3 (da) Fremgangsmåde til fremstilling af vanillin
DE19983678T1 (de) Bohrloch-Aktivierungssystem
ID27002A (id) Penghambat-penghambat kaspase
DK1080348T3 (da) Fremgangsmåde til detektering af farver
DE69830295D1 (de) Steuerungsverfahren
DE59910525D1 (de) Operationssystem
DE69906861D1 (de) Steuermethode
DE69815975D1 (de) Steuerungsverfahren
DE59811001D1 (de) Dichtungseinrichtung
DE69937857D1 (de) Lasersystem
FI980735A (fi) Viiveenhallintamenetelmä
NO20006531D0 (no) Kontrollmetode
ID27022A (id) Penghambat-penghambat fkbp
DE69937136D1 (de) Lackiervorrichtung
DE69816734D1 (de) Steuerungsverfahren
DE69932668D1 (de) Lasersystem
ID23196A (id) Gandaran untuk lampuflouresen
DE69906234T2 (de) Gummiervorrichtung
DE69903035D1 (de) Erwärmungsverfahren
DE69928612D1 (de) Dichtungseinrichtung